Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes

Biophysical Journal

Volumn 93, Issue 8, 2007, Pages 2743-2755

  Winkler, Kathrin ^a   Winter, Anja ^a,c   Rueckert, Christine ^b,d   Uchanska Ziegler, Barbara ^b   Alexiev, Ulrike ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; BETAINE; GLYCYLARGINYLPHENYLALANYLALANYLALANYLALANYLISOLEUCYLALANYLLYSINE; HLA B27 ANTIGEN; HLA B2705 ANTIGEN; HLA B2709 ANTIGEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLOSTERISM; AMINO ACID SUBSTITUTION; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DEPOLARIZATION; ENERGY; FLUORESCENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MECHANICS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN SECRETION; TEMPERATURE; THERMODYNAMICS;

EID: 35348937601     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.096602     Document Type: Article

References (31)

1. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587-622.
2. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323-358.
3. Saper, M. A., P. J. Bjorkman, and D. C. Wiley. 1991. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219:277-319.
4. Horten, R., L. Wilming, V. Rand, R. C. Lovering, E. A. Bruford, V. K. Khodiyar, M. J. Lush, S. Povey, C. C. Talbot, Jr., M. W. Wright, H. M. Wain, J. Trowsdale, A. Ziegler, and S. Beck. 2004. Gene map of the extended human MHC. Nature Rev. Gen. 5:889-899.
5. Khan, M. A. 2002. Update on spondyloarthropathies. Ann. Intern. Med. 136:896-907.
6. Ramos, M., and J. A. López de Castro. 2002. HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens. 60:191-205.
7. Kim, T.-H., W.-S. Uhm, and R. D. Inman. 2005. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr. Opin. Rheumatol. 17:400-405.
8. Gonzalez-Roces, S., M. V. Alvarez, S. Gonzalez, A. Dieye, H. Makni, D. G. Woodfield, L. Housan, V. Konenkov, M. C. Abbadi, N. Grunnet, E. Coto, and C. Lopez-Larrea. 1997. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens. 49:116-123.
9. D'Amato, M., M. T. Fiorillo, C. Carcassi, A. Mathieu, A. Zuccarelli, P. P. Bitti, R. Tosi, and R. Sorrentino. 1995. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 25:3199-3201.
10. 116 substitution in a novel HLA-B27 subtype influences the acceptance of the peptide C-terminal anchor. Immunogenetics. 41:38-39.
11. Ramos, M., A. Paradela, M. Vázquez, A. Marina, J. Vázquez, and J. A. López de Castro. 2002. Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J. Biol. Chem. 277:28749-28756.
12. Hülsmeyer, M., R. C. Hillig, A. Volz, M. Rühl, W. Schröder, W. Saenger, A. Ziegler, and B. Uchanska-Ziegler. 2002. HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J. Biol. Chem. 277:47844-47853.
13. Pöhlmann, T., R. A. Böckmann, H. Grubmüller, B. Uchanska-Ziegler, A. Ziegler, and U. Alexiev. 2004. Differential peptide dynamics is linked to major histocompatibility complex polymorphism. J. Biol. Chem. 279:28197-28201.
14. Hillig, R., M. Hülsmeyer, W. Saenger, K. Welfle, R. Misselwitz, H. Welfle, C. Kozerski, A. Volz, B. Uchanska-Ziegler, and A. Ziegler. 2004. Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J. Biol. Chem. 279:652-663.
15. Binz, A.-K., R. C. Rodriguez, W. E. Biddison, and B. M. Baker. 2003. Thermodynamic and kinetic analysis of a peptide-class I MHC interaction highlights the noncovalent nature and conformational dynamics of the class I heterotrimer. Biochemistry. 42:4954-4961.
16. Gakamsky, D. M., D. M. Davis, J. L. Strominger, and I. Pecht. 2000. Assembly and dissociation of human leukocyte antigen HLA-A2 studied by real-time fluorescence resonance energy transfer. Biochemistry. 39:11163-11169.
17. Gakamsky, D. M., P. J. Bjorkman, and I. Pecht. 1996. Peptide interaction with a Class I major histocompatibility complex-encoded molecule: allosteric control of the ternary complex stability. Biochemistry. 35:14841-14848.
18. Gakamsky, D. M., L. F. Boyd, D. H. Margulies, D. M. Davis, J. L. Strominger, and I. Pecht. 1999. An allosteric mechanism controls antigen presentation by the H-2K complex. Biochemistry. 38:12165-12173.
19. Strong, R. K., M. A. Holmes, P. Li, L. Braun, N. Lee, and D. E. Geraghty. 2003. HLA-E allelic variants. J. Biol. Chem. 278:5082-5090.
20. Dédier, S., S. Reinelt, T. Reitinger, G. Folkers, and D. Rognan. 2000. Thermodynamic stability of HLA-B*2705-peptide complexes. Effect of peptide and major histocompatibility complex protein mutations. J. Biol. Chem. 275:27055-27061.
21. Dédier, S., S. Reinelt, S. Rion, G. Folkers, and D. Rognan. 2001. Use of fluorescence polarization to monitor MHC-peptide interactions in solution. J. Immunol. Methods. 255:57-66.
22. Reinelt, S., S. Dédier, G. Asuni, G. Folkers, and D. Rognan. 2001. Mutation of Cys-67 alters the thermodynamic stability of the human leukocyte antigen HLA-B*2705. J. Biol. Chem. 276:18472-18477.
23. Hülsmeyer, M., K. Welfle, T. Pöhlmann, R. Misselwitz, U. Alexiev, H. Welfle, W. Saenger, B. Uchanska-Ziegler, and A. Ziegler. 2005. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. J. Mol. Biol. 346:1367-1379.
24. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA. 89:3429-3433.
25. Menssen, R., P. Orth, A. Ziegler, and W. Saenger. 1999. Decamer-like conformation of a non-peptide bound to HLA-B*3501 due to non-standard positioning of the C-terminus. J. Mol. Biol. 285:645-653.
26. Eftink, M. R. 1994. The use of fluorescence methods to monitor unfolding transitions in proteins. Biophys. J. 66:482-501.
27. Alexiev, U., I. Rimke, and T. Pöhlmann. 2003. Elucidation of the nature of the conformational changes of the EF-interhelical loop in bacteriorhodopsin and of the helix 8 on the cytoplasmic surface of bovine rhodopsin: a time-resolved fluorescence depolarization study. J. Mol. Biol. 328:705-719.
28. Lee, K. C., J. Siegel, S. E. D. Webb, S. Lévêque-Fort, M. J. Cole, R. Jones, K. Dowling, M. J. Lever, and P. M. W. French. 2001. Application of the stretched exponential function to fluorescence lifetime imaging. Biophys. J. 81:1265-1274.
29. López de Castro, J. A., I. Alvarez, M. Marcilla, A. Paradela, M. Ramos, L. Sesma, and M. Vázquez. 2004. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens. 63:424-445.
30. Madden, D. R., J. C. Gorga, J. L. Strominger, and D. C. Wiley. 1992. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 70:1035-1048.
31. 2m-deposition disease? Trends Immunol. 24:73-76.